DK162647C - Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner - Google Patents

Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner

Info

Publication number
DK162647C
DK162647C DK214685A DK214685A DK162647C DK 162647 C DK162647 C DK 162647C DK 214685 A DK214685 A DK 214685A DK 214685 A DK214685 A DK 214685A DK 162647 C DK162647 C DK 162647C
Authority
DK
Denmark
Prior art keywords
imidazorifamycines
procedure
preparing pyrido
pyrido
preparing
Prior art date
Application number
DK214685A
Other languages
Danish (da)
English (en)
Other versions
DK162647B (da
DK214685D0 (da
DK214685A (da
Inventor
Vincenzo Cannata
Gian Franco Tamagnone
Silvano Piani
Egidio Marchi
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of DK214685D0 publication Critical patent/DK214685D0/da
Publication of DK214685A publication Critical patent/DK214685A/da
Publication of DK162647B publication Critical patent/DK162647B/da
Application granted granted Critical
Publication of DK162647C publication Critical patent/DK162647C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK214685A 1984-05-15 1985-05-14 Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner DK162647C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT03463/84A IT1199374B (it) 1984-05-15 1984-05-15 Processo per la preparazione di pirido-imidazo-rifamicine
IT346384 1984-05-15

Publications (4)

Publication Number Publication Date
DK214685D0 DK214685D0 (da) 1985-05-14
DK214685A DK214685A (da) 1985-11-16
DK162647B DK162647B (da) 1991-11-25
DK162647C true DK162647C (da) 1992-04-13

Family

ID=11107845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK214685A DK162647C (da) 1984-05-15 1985-05-14 Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner

Country Status (18)

Country Link
US (1) US4557866A (enExample)
EP (1) EP0161534B1 (enExample)
JP (1) JPS60252483A (enExample)
AR (1) AR241913A1 (enExample)
AT (1) ATE46512T1 (enExample)
AU (1) AU568934B2 (enExample)
CA (1) CA1215708A (enExample)
DE (1) DE3573120D1 (enExample)
DK (1) DK162647C (enExample)
ES (1) ES543115A0 (enExample)
FI (1) FI81101C (enExample)
GR (1) GR851144B (enExample)
IE (1) IE58392B1 (enExample)
IT (1) IT1199374B (enExample)
NO (1) NO164242C (enExample)
PH (1) PH22007A (enExample)
PT (1) PT80446B (enExample)
ZA (1) ZA852971B (enExample)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
AU2002364162A1 (en) * 2001-12-13 2003-06-30 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
US7906542B2 (en) 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US7923553B2 (en) 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7902206B2 (en) 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
ITMI20032144A1 (it) 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
DK1698630T3 (da) * 2005-03-03 2014-12-08 Alfa Wassermann Spa Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
ITBO20050123A1 (it) * 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
CN101594885B (zh) 2006-03-09 2017-07-18 萨利克斯药品公司 利福昔明抗直肠功能障碍制剂
KR20150132214A (ko) 2006-08-02 2015-11-25 샐릭스 파마슈티컬스 인코포레이티드 방사선 직장ｓ상결장염의 치료를 위한 조성물 및 방법
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
JP2010504314A (ja) * 2006-09-22 2010-02-12 シプラ・リミテッド リファキシミン
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
US7709634B2 (en) 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
US8486956B2 (en) * 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
MY158257A (en) 2008-02-25 2016-09-30 Salix Pharmaceuticals Ltd Forms of rifaximin and uses thereof
RU2519649C2 (ru) 2008-02-26 2014-06-20 Саликс Фармасьютикалз, Лтд. Способы лечения заболеваний кишечника
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
ES2509892T3 (es) 2008-05-07 2014-10-20 Salix Pharmaceuticals, Ltd. Administración de un agente para limpieza del intestino y antibiótico para el tratamiento de enfermedad intestinal
CN101585843B (zh) * 2008-05-21 2011-07-06 重庆赛诺生物药业股份有限公司 一种利福昔明的制备工艺
US7928115B2 (en) * 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
US20110035232A1 (en) * 2008-10-02 2011-02-10 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
US12285414B2 (en) 2008-10-02 2025-04-29 Salix Pharmaceuticals, Inc. Methods of treating hepatic encephalopathy
MX364102B (es) 2008-10-02 2019-04-12 Salix Pharmaceuticals Ltd Medicamentos para usarse en el tratamiento de la encefalopatía hepática.
WO2010067072A1 (en) 2008-12-10 2010-06-17 Cipla Limited Rifaximin complexes
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
BRPI1010028A2 (pt) 2009-06-02 2019-02-12 Salix Pharmaceuticals, Ltd. métodos de tratamento de encefalopatia hepática
WO2011032085A1 (en) 2009-09-13 2011-03-17 Salix Pharmaceuticals, Ltd. Methods for treating irritable bowel syndrome (ibs)
WO2011061519A2 (en) 2009-11-23 2011-05-26 Cipla Limited Topical foam composition
EP2401282B2 (en) 2009-12-28 2017-01-04 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
EP3650022A1 (en) 2010-02-18 2020-05-13 Salix Pharmaceuticals, Ltd. Methods for treating rifampin resistant clostridium difficilis infections
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
WO2011156897A2 (en) * 2010-06-16 2011-12-22 Apotex Pharmachem Inc. Polymorphic forms of rifaximin
NZ605232A (en) 2010-07-12 2015-09-25 Salix Pharmaceuticals Ltd Formulations of rifaximin and uses thereof
US8759513B2 (en) 2010-09-13 2014-06-24 Sequent Scientific Limited Polymorphic form of rifaximin and process for its preparation
CN103827122B (zh) 2011-02-11 2016-08-31 萨利克斯药品有限公司 利福昔明的形式及其用途
AU2012251385A1 (en) 2011-05-02 2013-11-21 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
WO2012155981A1 (en) 2011-05-19 2012-11-22 Friulchem Spa New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
PL2773205T3 (pl) 2011-11-02 2024-09-02 Salix Pharmaceuticals, Inc. Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwego
US9359374B2 (en) 2012-06-13 2016-06-07 Apotex Pharmachem Inc. Polymorphic forms of rifaximin
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014140988A1 (en) 2013-03-15 2014-09-18 Alfa Wassermann S.P.A. Rifaximin for use in the treating of vaginal infections.
US20160047819A1 (en) 2013-03-15 2016-02-18 Alfa Wassermann S.P.A. Method for diagnosing vaginal infections
JP6433980B2 (ja) 2013-04-12 2018-12-05 アルファシグマ ソシエタ ペル アチオニ Ｎｓａｉｄ投与並びに関連する組成物、方法及びシステム
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ITMI20131307A1 (it) 2013-08-02 2015-02-02 A M S A Anonima Materie Sint & Affini S P A Processo per la preparazione di refaximina k
CN103509038B (zh) * 2013-09-30 2016-01-20 浙江思贤制药有限公司 一种新晶型利福昔明ζ及其制备方法
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
JP6693946B2 (ja) 2014-05-04 2020-05-13 サリックス ファーマスーティカルズ，インコーポレーテッド Ｉｂｓ微生物叢及びその使用
PL3143027T3 (pl) 2014-05-12 2019-11-29 Alfasigma Spa Nowe solwatowane krystaliczne postaci rifaksyminy, ich wytwarzanie, kompozycje i zastosowania
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
CN110072525B (zh) 2016-09-30 2022-12-02 萨利克斯药品公司 利福昔明的固态分散形式
CN110770244A (zh) * 2017-06-26 2020-02-07 倍尔福股份公司 吡啶并咪唑利福霉素衍生物的抗菌剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154655B (it) * 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Also Published As

Publication number Publication date
PT80446B (pt) 1987-11-11
EP0161534A3 (en) 1987-03-04
EP0161534A2 (en) 1985-11-21
DE3573120D1 (en) 1989-10-26
FI851907L (fi) 1985-11-16
IE58392B1 (en) 1993-09-08
NO164242C (no) 1990-09-12
AR241913A1 (es) 1993-01-29
JPH0469634B2 (enExample) 1992-11-06
IT8403463A0 (it) 1984-05-15
ATE46512T1 (de) 1989-10-15
NO164242B (no) 1990-06-05
DK162647B (da) 1991-11-25
NO851921L (no) 1985-11-18
JPS60252483A (ja) 1985-12-13
DK214685D0 (da) 1985-05-14
CA1215708A (en) 1986-12-23
FI81101B (fi) 1990-05-31
IT1199374B (it) 1988-12-30
FI81101C (fi) 1990-09-10
IE851191L (en) 1985-11-15
ZA852971B (en) 1985-12-24
DK214685A (da) 1985-11-16
PH22007A (en) 1988-05-02
ES8603489A1 (es) 1986-01-01
EP0161534B1 (en) 1989-09-20
PT80446A (en) 1985-06-01
AU4251585A (en) 1985-11-21
GR851144B (enExample) 1985-11-25
US4557866A (en) 1985-12-10
ES543115A0 (es) 1986-01-01
FI851907A0 (fi) 1985-05-14
AU568934B2 (en) 1988-01-14

Similar Documents

Publication Publication Date Title
DK162647C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK308085D0 (da) Fremgangsmaade til ekstrudering af silicaholdige materialer
DK301986D0 (da) Fremgangsmaade til fremstilling af 1-hydroxyvitamin-d-forbindelser
DK302086D0 (da) Fremgangsmaade til fremstilling af 1 alfa-hydroxyvitamin-d-forbindelser
DK162580C (da) Fremgangsmaade til fremstilling af mikrokapsler
DK606084D0 (da) Fremgangsmaade til fremstilling af 2-fluor-17beta-oestradiol
DK386784D0 (da) Fremgangsmaade til fremstilling af alfa-6-desoxy-tetracykliner
DK160829C (da) Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner
DK156085A (da) Fremgangsmaade til fremstilling af acetoxyazetidinoner
DK161788D0 (da) Fremgangsmaade til fremstilling af zidovudin
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK37890A (da) Fremgangsmaade til fremstilling af 6-deoxyanthracycliner
DK304185D0 (da) Fremgangsmaade til fremstilling af furanon
DK361387D0 (da) Fremgangsmaade til fremstilling af piperidinopyrimidin
DK573184A (da) Fremgangsmaade til fremstilling af polyphenylenoxid
DK350288D0 (da) Fremgangsmaade til fremstilling af n-epoxypropyllactamer
DK215082A (da) Fremgangsmaade til fremstilling af 2-iminotiazolidinderivater
DK27988D0 (da) Fremgangsmaade til fremstilling af substituerede benzaldehyder
DK40284D0 (da) Fremgangsmaade til fremstilling af n-phosphonmethylglycin
DK521885A (da) Fremgangsmaade til fremstilling af benzopyranotriazoler
DK377685A (da) Fremgangsmaade til fremstilling af krystallinske silicophosphoaluminater
DK575584D0 (da) Fremgangsmaade til fremstilling af polyphenylenoxid
DK98287A (da) Fremgangsmaade til fremstilling af imidazolylthiophenaldehyder
DK987D0 (da) Fremgangsmaade til fremstilling af tetrachlorpyri- din
DK154425C (da) Fremgangsmaade til fremstilling af carnitinchlorid

Legal Events

Date Code Title Description
PUP Patent expired